These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14692043)

  • 21. Let's not relive the past: a review of cancer risk after diagnostic or therapeutic irradiation.
    Ron E
    Pediatr Radiol; 2002 Oct; 32(10):739-44; discussion 751-4. PubMed ID: 12244466
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimation of cancer risks from radiotherapy of benign diseases.
    Trott KR; Kamprad F
    Strahlenther Onkol; 2006 Aug; 182(8):431-6. PubMed ID: 16896588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
    Tubiana M
    Radiother Oncol; 2009 Apr; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary neoplasms after radiotherapy for a childhood solid tumor.
    Paulino AC; Fowler BZ
    Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of protons on the incidence of second malignancies in radiotherapy by Eric J. Hall; Supp.31-34 2007.
    Paganetti H
    Technol Cancer Res Treat; 2007 Dec; 6(6):661-2. PubMed ID: 17994798
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma.
    Paulino AC; Ahmed IM; Mai WY; Teh BS
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1408-14. PubMed ID: 19394163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review.
    Kirova YM; Vilcoq JR; Asselain B; Sastre-Garau X; Fourquet A
    Cancer; 2005 Aug; 104(4):856-63. PubMed ID: 15981282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple intracranial aneurysms following radiation therapy for pituitary adenoma. Case report].
    Nishi T; Matsukado Y; Kodama T; Hiraki T
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):224-8. PubMed ID: 2442647
    [No Abstract]   [Full Text] [Related]  

  • 30. Tomotherapy planning of small brain tumours.
    Yartsev S; Kron T; Cozzi L; Fogliata A; Bauman G
    Radiother Oncol; 2005 Jan; 74(1):49-52. PubMed ID: 15683669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant neoplasms from radiotherapy of benign diseases].
    Hamada M; Sakai K; Hashimoto S
    Rinsho Hoshasen; 1981 Jun; 26(6):663-70. PubMed ID: 7277770
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radiation fibrosarcoma of the pituitary].
    Vikhert TM; Kasumova SIu
    Zh Vopr Neirokhir Im N N Burdenko; 1980; (4):57-8. PubMed ID: 7424324
    [No Abstract]   [Full Text] [Related]  

  • 34. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
    Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):795-808. PubMed ID: 15708259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
    Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
    Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current role of radiation therapy in the management of histiocytosis-X.
    Cassady JR
    Hematol Oncol Clin North Am; 1987 Mar; 1(1):123-9. PubMed ID: 3312144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of second cancers after radiotherapy for cervical cancer.
    Ohno T; Kakinuma S; Kato S; Tsujii H; Shimada Y
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):49-57. PubMed ID: 16375644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of risk estimation models for the induction of secondary cancers following radiotherapy.
    Daşu A; Toma-Daşu I; Olofsson J; Karlsson M
    Acta Oncol; 2005; 44(4):339-47. PubMed ID: 16120542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant astrocytoma following radiation for nasopharyngeal carcinoma: case report and review of the literature.
    Lin KC; Cheng TJ; Yung JM; Kuo JR
    Acta Neurol Taiwan; 2007 Mar; 16(1):27-32. PubMed ID: 17486730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.